HoldsUp

Robert H. Lustig

Robert H. Lustig is a researcher and author focused on pediatric health, nutrition, and metabolic disease. His published research investigates the biochemical and environmental mechanisms driving obesity, including the health impacts of dietary fructose, ultraprocessed foods, and chemical obesogens. He also studies pediatric endocrine and growth outcomes, food addiction, and the influence of industry practices on chronic disease.

43 claims checked on air: 6 context 7 contradicted 7 overstated 17 supported 6 unverified

What they said on air - contradicted

2 citing their own research

0:19:22contradictedhighTake Back Your Health - with Dr. Robert H. Lustig | The Empo

There are more metabolically unhealthy normal-weight individuals in the United States than metabolically unhealthy obese individuals.

"And actually it turns out there are more thin, sick people in America than there are fat, sick people" (said at 0:19:22)

Nationally representative data from the National Health and Nutrition Examination Survey (NHANES) contradict the claim that there are more metabolically unhealthy normal-weight individuals ("thin, sick") in the United States than metabolically unhealthy obese individuals ("fat, sick"). An analysis of NHANES data from 1999 to 2018 (PMID: 35691704) found that the prevalence of metabolically unhealthy normal weight was 2.10% (declining from 3.77% in 1999), compared to a prevalence of 26.4% for metabolically unhealthy obesity (increasing from 19.0% in 1999). Even when looking at broader definitions or proportions within BMI categories (PMID: 26841729), approximately 30% of normal-weight US adults are cardiometabolically unhealthy compared to about 71% of obese adults (and 84% of class II/III obese adults), resulting in a substantially larger absolute and relative population of metabolically unhealthy individuals in the overweight and obese categories compared to the normal-weight category.

0:35:54contradictedhighTake Back Your Health - with Dr. Robert H. Lustig | The Empo

Exercise does not reduce glycation and actually makes glycation worse.

"So it does not affect glycation; it actually makes glycation worse." (said at 0:35:54)

The claim that exercise does not reduce glycation and actually worsens it is directly contradicted by clinical trial and epidemiological evidence. Large meta-analyses of hundreds of randomized controlled trials show that exercise training consistently lowers glycated hemoglobin (HbA1c), a primary biomarker of protein glycation. Furthermore, a systematic review investigating the accumulation of advanced glycation end products (AGEs, measured via skin autofluorescence) found that higher physical activity and exercise levels are inversely associated with tissue glycation, with no studies finding that physical activity increases or worsens glycation accumulation.

0:35:59contradictedhighTake Back Your Health - with Dr. Robert H. Lustig | The Empo

Exercise does not reduce oxidative stress and actually makes oxidative stress worse.

"It does not affect oxidative stress; exercise actually makes oxidative stress worse." (said at 0:35:59)

The claim that exercise does not reduce oxidative stress and only worsens it is contradicted by systematic reviews and meta-analyses of randomized controlled trials. While a single, acute bout of strenuous exercise causes a transient increase in reactive oxygen species and oxidative stress biomarkers (such as protein carbonyls and F2-isoprostanes), regular exercise training induces adaptative increases in endogenous antioxidant enzymes (such as superoxide dismutase) and causes a net reduction in basal pro-oxidants and lipid peroxidation markers (such as malondialdehyde).

0:53:12contradictedmoderateTake Back Your Health - with Dr. Robert H. Lustig | The Empo

African Americans accumulate less hepatic fat on average due to a mutation in the APOC3 gene.

"In African Americans, it should be 20 for that matter because they actually don't even make as much fat in the liver. They have a mutation in their APOC3 gene, so they actually don't accumulate as much fat." (said at 0:53:12)

The claim that African Americans accumulate less hepatic fat due to a mutation in the APOC3 gene is contradicted by population-based genetics studies examining APOC3 variants, hepatic triglyceride content (HTGC), and ethnicity. In a large multiethnic cohort study (the Dallas Heart Study, n=1,228 African Americans), candidate APOC3 gene variants (rs2854117 and rs2854116) showed no significant difference in hepatic fat content between carriers and noncarriers, refuting the proposed role of APOC3 variants in driving lower hepatic fat accumulation in African Americans (PMID: 21274868). Similarly, in obese pediatric cohorts evaluated across racial groups, APOC3 gene variants were not associated with hepatic fat fraction, whereas variants in genes such as PNPLA3 and GCKR were associated with liver fat accumulation across ethnicities (PMID: 22105854).

1:01:26contradictedhighTake Back Your Health - with Dr. Robert H. Lustig | The Empo

Homocysteine is normally metabolized through the urea cycle to succinate by the enzyme methylenetetrahydrofolate reductase (MTHFR).

"And the thing is that homocysteine is normally metabolized down the urea cycle to succinate by the enzyme MTHFR, methylenetetrahydrofolate reductase." (said at 1:01:26)

The speaker fundamentally misstates the biochemistry of homocysteine metabolism. Homocysteine is not metabolized through the urea cycle to succinate by methylenetetrahydrofolate reductase (MTHFR). In human biochemistry, homocysteine has two major pathways: remethylation back to methionine and transsulfuration to cysteine. MTHFR catalyzes the conversion of 5,10-methylenetetrahydrofolate to 5-methyltetrahydrofolate, which provides the methyl group used by methionine synthase to remethylate homocysteine into methionine. The urea cycle is a distinct pathway responsible for ammonia detoxification, and succinate is an intermediate of the citric acid (TCA) cycle.

1:07:40contradictedhighTake Back Your Health - with Dr. Robert H. Lustig | The Empo

ACE2 is normally a water channel in cells, especially in the lungs.

"ACE2, angiotensin-converting enzyme 2. Now, that is normally a water channel in cells, especially lung, but it drives the production of ACE2." (said at 1:07:40)

ACE2 (angiotensin-converting enzyme 2) is not a water channel; it is a membrane-bound zinc carboxypeptidase within the renin-angiotensin system that cleaves angiotensin II into angiotensin-(1-7) and serves as the cellular entry receptor for SARS-CoV and SARS-CoV-2. The cellular proteins that function as water channels are aquaporins (e.g., AQP1 through AQP5), which the speaker may have confused with ACE2 due to the similar abbreviation of Aquaporin-2 (AQP2).

1:08:40contradictedmoderateTake Back Your Health - with Dr. Robert H. Lustig | The Empo

High blood glucose crystallizes around ACE2 molecules to keep them open, increasing susceptibility to COVID-19 infection.

"High blood glucose basically crystallizes around the edges of those ACE2 molecules and keeps them open so that the virus has an even easier chance of infecting you." (said at 1:08:40)

The claim mischaracterizes the biochemistry of hyperglycemia and SARS-CoV-2 receptor interaction. Glucose does not physically "crystallize" on cell-surface receptors in aqueous biological fluids. In patients with elevated blood glucose, the actual molecular mechanism involves non-enzymatic glycation (the covalent attachment of glucose molecules to lysine residues) and increased cellular expression of ACE2. Furthermore, in silico structural modeling indicates that glycation of ACE2 residues reduces polar and van der Waals interactions with the viral Spike protein rather than mechanically holding the receptor open.

Fact-checked episodes

Publications